Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA Ā· Real-Time Price Ā· USD
146.94
+1.17 (0.80%)
Nov 20, 2026, 11:55 AM EST - Market open
Palvella Therapeutics Employees
Palvella Therapeutics had 29 employees as of December 31, 2025. The number of employees increased by 15 or 107.14% compared to the previous year. That makes Palvella Therapeutics the 37,311th largest employer in the world and 5,190th in the United States.
Employees
29
Change (1Y)
15
Growth (1Y)
107.14%
Revenue / Employee
n/a
Profits / Employee
-$2,586,000
Market Cap
2.15B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | 15 | 107.14% |
| Dec 31, 2024 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 557 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Immunome | 267 |
| Celldex Therapeutics | 198 |
| Lakefront Biotherapeutics NV | 196 |
PVLA News
- 1 day ago - Palvella Therapeutics Transcript: Status update - Transcripts
- 1 day ago - Palvella Therapeutics Press release: Status update - Filings
- 1 day ago - Palvella Therapeutics Slides: Status update - Filings
- 1 day ago - Palvella Therapeutics Announces QTORIN⢠Docetaxel, a New QTORIN⢠Program for the Treatment of Extramammary Paget's Disease (EMPD) - GlobeNewsWire
- 1 day ago - Palvella Therapeutics to Host Webcast to Introduce New QTORIN⢠Program - GlobeNewsWire
- 4 days ago - Leerink bullish on Palvella Therapeutics, initiates with an Outperform - TheFly
- 4 days ago - Palvella Therapeutics initiated with an Outperform at Leerink - TheFly
- 10 days ago - Palvella Therapeutics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts